SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BRAVEHEART who wrote (860)7/30/1999 1:32:00 PM
From: sam_b  Read Replies (1) of 1386
 
The article just said MR.Carl Icahn consider to invest in Pharmos.
Also said that Mr. Haim Aviv even no met him .
Carl spent 2 years in medical school.
His capital $2.2B .
I like the idea that Carl will invest as a financial partner in Pharmos.
For him $30M is less than pocket money.We don't need more.
I also prefer Pharmos manage P3 WITHOUT BIG PHARMA.
The only value added of big pharma as partner is a prestige.
It's good for the ego but gives Pharmos much much less in the bottom
line.
Pharmos will make a contract with Carl or other financial groups
similar to a contract with big pharma but just for finance terms.
With this kind of contract as a financial partner there is no
transfer of shares.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext